Fortress Biotech Inc (FBIO)
1.78
-0.09
(-4.81%)
USD |
NASDAQ |
May 28, 16:00
1.76
-0.02
(-1.12%)
After-Hours: 20:00
Fortress Biotech Enterprise Value: -9.070M for May 24, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 24, 2024 | -9.070M |
| May 23, 2024 | -9.667M |
| May 22, 2024 | -9.070M |
| May 21, 2024 | -6.879M |
| May 20, 2024 | -7.477M |
| May 17, 2024 | -7.875M |
| May 16, 2024 | -11.26M |
| May 15, 2024 | -11.66M |
| May 14, 2024 | -11.26M |
| May 13, 2024 | -12.46M |
| May 10, 2024 | -13.96M |
| May 09, 2024 | -13.18M |
| May 08, 2024 | -12.41M |
| May 07, 2024 | -11.82M |
| May 06, 2024 | -11.82M |
| May 03, 2024 | -12.41M |
| May 02, 2024 | -11.44M |
| May 01, 2024 | -12.60M |
| April 30, 2024 | -13.96M |
| April 29, 2024 | -12.99M |
| April 26, 2024 | -12.99M |
| April 25, 2024 | -12.99M |
| April 24, 2024 | -11.63M |
| April 23, 2024 | -11.24M |
| April 22, 2024 | -12.41M |
| Date | Value |
|---|---|
| April 19, 2024 | -12.41M |
| April 18, 2024 | -11.24M |
| April 17, 2024 | -12.02M |
| April 16, 2024 | -12.21M |
| April 15, 2024 | -11.05M |
| April 12, 2024 | -11.44M |
| April 11, 2024 | -11.05M |
| April 10, 2024 | -9.306M |
| April 09, 2024 | -9.694M |
| April 08, 2024 | -9.500M |
| April 05, 2024 | -10.08M |
| April 04, 2024 | -10.08M |
| April 03, 2024 | -9.112M |
| April 02, 2024 | -8.919M |
| April 01, 2024 | -7.756M |
| March 31, 2024 | -7.562M |
| March 28, 2024 | 0.444M |
| March 27, 2024 | 3.714M |
| March 26, 2024 | -2.558M |
| March 25, 2024 | -2.925M |
| March 22, 2024 | -2.466M |
| March 21, 2024 | -1.823M |
| March 20, 2024 | -2.925M |
| March 19, 2024 | -3.201M |
| March 18, 2024 | -2.742M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-41.71M
Minimum
Nov 10 2023
444.49M
Maximum
Apr 12 2021
111.99M
Average
89.55M
Median
Oct 15 2019
Enterprise Value Benchmarks
| Journey Medical Corp | 62.67M |
| Avenue Therapeutics Inc | -0.7256M |
| Checkpoint Therapeutics Inc | 56.56M |
| Mustang Bio Inc | 1.290M |
| Viking Therapeutics Inc | 5.956B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -15.42M |
| Revenue (Quarterly) | 13.03M |
| Total Expenses (Quarterly) | 49.60M |
| EPS Diluted (Quarterly) | -1.03 |
| Gross Profit Margin (Quarterly) | 47.69% |
| Profit Margin (Quarterly) | -118.3% |
| Earnings Yield | -346.4% |
| Normalized Earnings Yield | -304.19 |